Where Does Soleno Therapeutics Inc (SLNO) Stock Fall in the Biotechnology Field After It Has Gained 3.65% This Week?
Mentioned in this article
Soleno Therapeutics Inc (SLNO) is near the top in its industry group according to InvestorsObserver. SLNO gets an overall rating of 70. That means it scores higher than 70 percent of stocks. Soleno Therapeutics Inc gets a 84 rank in the Biotechnology industry. Biotechnology is number 27 out of 148 industries.
What do These Ratings Mean?
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What’s Happening With Soleno Therapeutics Inc Stock Today?
Soleno Therapeutics Inc (SLNO) stock has gained 6.42% while the S&P 500 is down -0.12% as of 2:28 PM on Monday, Feb 5. SLNO has risen $3.00 from the previous closing price of $46.74 on volume of 280,936 shares. Over the past year the S&P 500 has gained 20.47% while SLNO has risen 2043.97%. SLNO lost -$3.30 per share the over the last 12 months.
Click Here to get the full Stock Report for Soleno Therapeutics Inc stock.
